Metraipolis › archive › dc_56d733cb9814

Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma — Europe PMC PMID:41050702

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41050702
DOI
10.3389/fimmu.2025.1677723
License (as archived)
solo-consultazione
Archived
2026-11-09T21:21:56.852Z
SHA-256 of the archived text
a207da68215e44c54c775b4c2774bd2d2aac9f0eef6f051e3e7ec3018d1792ec
Stable URL of this page
https://metraipolis.com/documento/dc_56d733cb9814

How to cite

Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma — Europe PMC PMID:41050702 — Europe PMC (en), https://europepmc.org/article/MED/41050702 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56d733cb9814 (Metraipolis archive dc_56d733cb9814, sha256 a207da68215e44c54c775b4c2774bd2d2aac9f0eef6f051e3e7ec3018d1792ec)
BibTeX
@misc{dc56d733cb9814,
  title = {Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma — Europe PMC PMID:41050702},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41050702},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56d733cb9814; sha256 a207da68215e44c54c775b4c2774bd2d2aac9f0eef6f051e3e7ec3018d1792ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050702. Agents can read the archived copy with the MCP tool read_document.